Back to Search
Start Over
Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML).
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; 2019 Supplement 1, Vol. 19, pS217-S218, 2p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 19
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 142669374
- Full Text :
- https://doi.org/10.1016/j.clml.2019.07.090